Skip to main content
Premium Trial:

Request an Annual Quote

Response Genetics' Q1 Revenues Down 21 Percent

NEW YORK (GenomeWeb News) – Response Genetics reported after the close of the market on Thursday that its first-quarter revenues fell 21 percent and its net loss nearly doubled as it ramped up sales of its ResponseDX genetic test panels.

The Los Angeles-based firm brought in revenues of $1.5 million for the three-month period ended March 31, compared with revenues of $1.9 million for the first quarter of 2008. The firm said that the decrease was "primarily due to a delay in the receipt of clinical samples from one of our major pharmaceutical clients, which the company anticipates receiving in 2009 through 2010."

Response Genetics also said that the decline was partially offset by revenue of around $263,000 from sales of its ResponseDX: Lung and ResponseDX: Colon pharmacogenomic tests.

The firm posted a net loss of $3.3 million, or $.30 per share, up from a Q1 2008 net loss of $1.7 million, or $.17 per share.

Its R&D expenses edged up to $603,385 from $574,420 year over year, and its SG&A spending climbed to $2.5 million from $1.7 million.

Response Genetics finished the quarter with $10.2 million in cash and cash equivalents.

Filed under

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.